Enecadin

CAS No. 259525-01-4

Enecadin( —— )

Catalog No. M33214 CAS No. 259525-01-4

Enecadin is a neuroprotective agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 275 In Stock
10MG 380 In Stock
25MG 542 In Stock
50MG 710 In Stock
100MG 995 In Stock
200MG 1283 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Enecadin
  • Note
    Research use only, not for human use.
  • Brief Description
    Enecadin is a neuroprotective agent.
  • Description
    Enecadin is a neuroprotective agent extracted from patent US 8623823 B2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    259525-01-4
  • Formula Weight
    357.46
  • Molecular Formula
    C21H28FN3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 50 mg/mL (139.88 mM )
  • SMILES
    Cc1nc(OCCCCCN2CCCCC2)cc(n1)-c1ccc(F)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Anil Gulati. Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist. US 8623823 B2.
molnova catalog
related products
  • Cyanidin-3-Arabinosi...

    Cyanidin 3-arabinoside is a selective and reversible protein tyrosine phosphatase 1B (PTP1B) inhibitor, with an IC50 of 8.91 μM. Cyanidin 3-arabinoside is potential for the research of type 2 diabetes.

  • Nogo-66 (1-40)

    Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.

  • Juglanin D

    1-(4-Hydroxyphenyl)-2,3-dihydroxypropan-1-one is a compound that can be isolated from the leaves of C. formosensis.